Controlled-release pregabalin in the treatment of fibromyalgia

Alessandra Alciati, Fabiola Atzeni, Ignazio Francesco Masala, Mariateresa Cirillo, Davide Sciortino, Giampaolo Perna, Piercarlo Sarzi-Puttini

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)617-623
Number of pages7
JournalExpert Review of Neurotherapeutics
Volume18
Issue number8
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Fibromyalgia
  • pharmacological treatment
  • pregabalin
  • controlled-release pregabalin
  • HEALTH-CARE COSTS
  • PLACEBO-CONTROLLED TRIAL
  • OF-RHEUMATOLOGY 1990
  • PHASE-III TRIAL
  • DOUBLE-BLIND
  • MEDICATION ADHERENCE
  • DIAGNOSTIC-CRITERIA
  • DULOXETINE
  • PHARMACOKINETICS
  • METAANALYSIS

Cite this

Alciati, A., Atzeni, F., Masala, I. F., Cirillo, M., Sciortino, D., Perna, G., & Sarzi-Puttini, P. (2018). Controlled-release pregabalin in the treatment of fibromyalgia. Expert Review of Neurotherapeutics, 18(8), 617-623. https://doi.org/10.1080/14737175.2018.1508344